Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections
- PMID: 25849543
- PMCID: PMC4388470
- DOI: 10.1371/journal.ppat.1004782
Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections
Abstract
Epithelial cells are a major port of entry for many viruses, but the molecular networks which protect barrier surfaces against viral infections are incompletely understood. Viral infections induce simultaneous production of type I (IFN-α/β) and type III (IFN-λ) interferons. All nucleated cells are believed to respond to IFN-α/β, whereas IFN-λ responses are largely confined to epithelial cells. We observed that intestinal epithelial cells, unlike hematopoietic cells of this organ, express only very low levels of functional IFN-α/β receptors. Accordingly, after oral infection of IFN-α/β receptor-deficient mice, human reovirus type 3 specifically infected cells in the lamina propria but, strikingly, did not productively replicate in gut epithelial cells. By contrast, reovirus replicated almost exclusively in gut epithelial cells of IFN-λ receptor-deficient mice, suggesting that the gut mucosa is equipped with a compartmentalized IFN system in which epithelial cells mainly respond to IFN-λ that they produce after viral infection, whereas other cells of the gut mostly rely on IFN-α/β for antiviral defense. In suckling mice with IFN-λ receptor deficiency, reovirus replicated in the gut epithelium and additionally infected epithelial cells lining the bile ducts, indicating that infants may use IFN-λ for the control of virus infections in various epithelia-rich tissues. Thus, IFN-λ should be regarded as an autonomous virus defense system of the gut mucosa and other epithelial barriers that may have evolved to avoid unnecessarily frequent triggering of the IFN-α/β system which would induce exacerbated inflammation.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Expression of Ifnlr1 on Intestinal Epithelial Cells Is Critical to the Antiviral Effects of Interferon Lambda against Norovirus and Reovirus.J Virol. 2017 Mar 13;91(7):e02079-16. doi: 10.1128/JVI.02079-16. Print 2017 Apr 1. J Virol. 2017. PMID: 28077655 Free PMC article.
-
Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection.J Virol. 2018 Apr 27;92(10):e02062-17. doi: 10.1128/JVI.02062-17. Print 2018 May 15. J Virol. 2018. PMID: 29514905 Free PMC article.
-
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.Immunol Rev. 2008 Dec;226:29-40. doi: 10.1111/j.1600-065X.2008.00698.x. Immunol Rev. 2008. PMID: 19161414 Review.
-
Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection.J Neurovirol. 2011 Aug;17(4):314-26. doi: 10.1007/s13365-011-0038-1. Epub 2011 Jun 14. J Neurovirol. 2011. PMID: 21671121 Free PMC article.
-
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.Front Immunol. 2020 Dec 11;11:608645. doi: 10.3389/fimmu.2020.608645. eCollection 2020. Front Immunol. 2020. PMID: 33362795 Free PMC article. Review.
Cited by
-
Cell Intrinsic Determinants of Alpha Herpesvirus Latency and Pathogenesis in the Nervous System.Viruses. 2023 Nov 22;15(12):2284. doi: 10.3390/v15122284. Viruses. 2023. PMID: 38140525 Free PMC article. Review.
-
Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.PLoS Pathog. 2016 Jun 21;12(6):e1005684. doi: 10.1371/journal.ppat.1005684. eCollection 2016 Jun. PLoS Pathog. 2016. PMID: 27327515 Free PMC article.
-
Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance.PLoS Pathog. 2018 Nov 28;14(11):e1007420. doi: 10.1371/journal.ppat.1007420. eCollection 2018 Nov. PLoS Pathog. 2018. PMID: 30485383 Free PMC article.
-
Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.Curr Opin Immunol. 2019 Feb;56:67-75. doi: 10.1016/j.coi.2018.10.007. Epub 2018 Nov 3. Curr Opin Immunol. 2019. PMID: 30399529 Free PMC article. Review.
-
Re-Examining Rotavirus Innate Immune Evasion: Potential Applications of the Reverse Genetics System.mBio. 2022 Aug 30;13(4):e0130822. doi: 10.1128/mbio.01308-22. Epub 2022 Jun 14. mBio. 2022. PMID: 35699371 Free PMC article. Review.
References
-
- Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1–47. - PubMed
-
- van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M (1995) Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148: 5–18. - PubMed
-
- Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918–1921. - PubMed
-
- Krause CD, Pestka S (2005) Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol Ther 106: 299–346. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
